SARS-CoV-2 感染症は,プロファイブロティックおよびプロトロンボティック泡細胞形成を誘発する
Diana M Battaglia1,2,3,4, Claire E Post2,3,4, Wenbo Yao2,3,4,5
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Nature microbiology
|August 22, 2025
まとめ
重症急性呼吸器症候群コロナウイルス2型 (SARS-CoV-2型) 感染症は,マクロファージと泡細胞の形成が増加し,肺線維症に寄与する. 抗ウイルス治療はこれらの効果を予防し,COVID-19の合併症に対する治療目標を示唆した.
科学分野:
- 免疫学
- 病理学について
- ウイルス学
背景:
- COVID-19と長期COVIDは免疫機能の不調を伴うが,マクロファージの役割は不明である.
- マクロファージは重要な免疫細胞ですが,SARS-CoV-2の病原性におけるそれらの特定の関与は明らかにする必要があります.
研究 の 目的:
- SARS-CoV-2感染およびその後の肺病変におけるマクロファージの役割を調査する.
- 他のコロナウイルスと比較して,SARS-CoV-2-誘発のマクロファージの変化が特異的かどうかを判断する.
- COVID-19におけるマクロファージ関連病理に対する抗ウイルス治療の影響を評価する.
主な方法:
- ヒト化したマウス,レサス・マカック, 死後のヒトの肺組織を用いた.
- マクロファージの増殖,発泡細胞の形成,遺伝子発現のプロフィールを分析した.
- EIDD-2801 (抗ウイルス薬) の感染誘発病理学的効果を評価した.
主要な成果:
- SARS-CoV-2感染は,マクロファージの数を増やし,複数のモデルで泡細胞形成を引き起こした.
- 他のテストされたコロナウイルスはこれらのマクロファージ反応を誘導しませんでした.
- 発泡細胞は 線維性および血栓性遺伝子シグネチャーを示した.
- マクロファージの増加と肺線維症は,ウイルスのクリアランス後も続いた.
- EIDD-2801治療はマクロファージの増殖,発泡細胞の形成を抑制し,線維症マーカーを減少させた.
結論:
- SARS-CoV-2 感染症はマクロファージの蓄積と泡細胞の形成を特異的に促し,肺炎,線維症,血栓形成に寄与する.
- マクロファージはCOVID-19に関連した肺損傷において重要な役割を果たします.
- EIDD-2801による早期の抗ウイルス治療は,これらのマクロファージ媒介の病理的プロセスを緩和します.
さらに関連する動画
関連する概念動画
Coronary Artery Disease II: Pathophysiology
34
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
Inflammation
55.1K
Overview
55.1K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Atherosclerosis I: Introduction
77
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
77
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
46
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
46
Cystic Fibrosis: Pathogenesis
360
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
360


